A parasitologist working on L. major in a biocontainment hood
A Leishmaniasis vaccine is a vaccine which would prevent leishmaniasis. As of 2017, no vaccine for humans was available.[1][2] Currently some effective leishmaniasis vaccines for dogs exist.[3]
The parasite which causes leishmaniasis is Leishmania, which is a Trypanosomatida. The disease spreads from sandflies. Animals such as dogs can be a vector for having the parasite, spreading it to sandflies, and from sandflies to humans. A vaccination strategy to control or eliminate Leishmaniasis might include developing a vaccine for humans and other vaccines for animals.
Scientists wish for a vaccine and there is vaccine research.[4] There is also consideration that public health practices can control or eliminate leishmaniasis without a vaccine.[4]
^Cite error: The named reference Srivastava 2016 was invoked but never defined (see the help page).
^Ghorbani, M; Farhoudi, R (2018). "Leishmaniasis in humans: drug or vaccine therapy?". Drug Design, Development and Therapy. 12: 25–40. doi:10.2147/DDDT.S146521. PMC 5743117. PMID 29317800.
^Cite error: The named reference Moafi 2019 was invoked but never defined (see the help page).
^ abGhorbani, M; Farhoudi, R (2018). "Leishmaniasis in humans: drug or vaccine therapy?". Drug Design, Development and Therapy. 12: 25–40. doi:10.2147/DDDT.S146521. PMC 5743117. PMID 29317800.
and 28 Related for: Leishmaniasis vaccine information
A Leishmaniasisvaccine is a vaccine which would prevent leishmaniasis. As of 2017, no vaccine for humans was available. Currently some effective leishmaniasis...
no leishmaniasisvaccine for humans was available. Research to produce a human vaccine is ongoing. Currently some effective leishmaniasisvaccines for...
Canine leishmaniasis (LEESH-ma-NIGH-ah-sis) is a zoonotic disease (see human leishmaniasis) caused by Leishmania parasites transmitted by the bite of...
Visceral leishmaniasis (VL), also known as kala-azar (Hindi: kālā āzār, "black sickness") or "black fever", is the most severe form of leishmaniasis and,...
launched the world's first clinical trial of the visceral leishmaniasisvaccine. The vaccine is a recombinant form of two fused Leishmania parasite proteins...
2016). "Status of vaccine research and development of vaccines for leishmaniasis". Vaccine. 34 (26): 2992–2995. doi:10.1016/j.vaccine.2015.12.071. ISSN 1873-2518...
Cutaneous leishmaniasis is the most common form of leishmaniasis affecting humans. It is a skin infection caused by a single-celled parasite that is transmitted...
to develop an effective general use dengue vaccine. There is research for a kala azar (Leishmaniasis) vaccine in India, but none exists. Foreign tourists...
azar within 1 year. Post-kala-azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis (VL); it is characterised by a macular, maculopapular...
12 April 2019. Nakkazi, E. (March 12, 2012). "New vaccine trials to prevent visceral leishmaniasis". New Science Journalism. Retrieved June 16, 2013....
genus Leishmania, and is associated with the disease zoonotic cutaneous leishmaniasis (also known as Aleppo boil, Baghdad boil, Bay sore, Biskra button, Chiclero...
CB (25 March 2008). "Vaccines for leishmaniasis in the fore coming 25 years". Vaccine. 26 (14): 1709–24. doi:10.1016/j.vaccine.2008.01.023. PMID 18295939...
visceral leishmaniasis (VL) in East Africa available since 2010. It is the result of a six-year partnership between DNDi, the Leishmaniasis East Africa...
diarrheal diseases, dengue fever, and leishmaniasis. It has supported the testing and development of 40 different vaccine formulations that have progressed...
methodology for the study of DNA impressions and the American visceral leishmaniasisvaccine. Among the ICB topics of research responsible for the largest number...
Pipeline vaccine refers to vaccines which are under development. The World Health Organization's (WHO) Product Development for Vaccines Advisory Committee...
2016-03-04. Retrieved 2013-03-29. "Initiative for Vaccine Research (IVR): Parasitic Diseases – Leishmaniasis". World Health Organization. 2013. Archived from...
visceral leishmaniasis occur annually. It is a vector-borne disease caused by the bite of sandflies. At least 90 percent of visceral leishmaniasis occurs...
developing various therapeutics and vaccines, such as saRNA COVID-19 vaccine, influenza vaccine, and tuberculosis vaccine. Currently, he is the CEO of Compliment...
newspaper Zoonotic visceral leishmaniasis, a disease that may be linked to lutzomyia longipalpis Zoster vaccine live, vaccine against shingles ZVL Leiden...
visceral leishmaniasis, post-kala-azar dermal leishmaniasis (a variant of visceral leishmaniasis), viscerotropic leishmaniasis, and leishmaniasis recidivans...
addicts in the country who inject drugs into their bodies using syringes. Leishmaniasis is estimated to cause the ninth largest disease burden among infectious...
Cutaneous leishmaniasis can spread to the mucus membranes and cause mucosal leishmaniasis even years after the initial infection. Cutaneous leishmaniasis heals...
vector-borne diseases like dengue fever, malaria, tick-borne diseases, leishmaniasis, zika fever, chikungunya and Ebola. One mechanism contributing to increased...
diseases including leishmaniasis, Chagas disease, SARS, and MERS, As of 2020, he was also working in development of a Coronavirus vaccine. With Maria Elena...
Global Information